Pavlomir M.·Oct 23Moderna stock — When the stocks do opposite of what they shouldIt took me absolutely zero pre-existing knowledge about Moderna (NASDAQ: MRNA) to know I could profit from the company.
Deepak S.·Oct 22Moderna Stock Plunges 25% Following Early Cancer Vaccine Data Leak: What Investors Need to KnowThe biotechnology market experienced a sudden shock as shares of Moderna (NASDAQ: MRNA) plummeted by as much as 25%. The sharp sell-off was…
V.S Ferreira·Aug 21Moderna and Merck Just Changed Cancer History - Here’s What Actually Happened TodayThe personalized mRNA vaccine intismeran + Keytruda succeeded in a 1,137-patient melanoma trial. But the real story is bigger.
Casi Borg·Jun 2What if your body could fight cancer — before it even comes back?Scientists just proved a vaccine built from your own tumor can keep melanoma away for five years. This changes everything.
